|Articles|August 10, 2011

Medical Economics Digital Edition - 08/10/2011

Tap Into New Revenue Streams

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics Digital Edition - 08/10/2011

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Saving America's primary care system requires bold action now

10 ways AI is creeping into medical care

Medicare's new drug pricing plan could backfire, driving up prices worldwide, study warns

New partnerships or fragmented care? A primary care leader discusses Medicare’s ACCESS model

New Medicare ACCESS model aims to reward results, not volume, for chronic disease care